Inventor · disambiguated record
Ute Hoch
Also filed as: HOCH UTE
3 granted patents·6 pending applications·7 citations·filing 2009–2020
61Inventor score
Top patents by PatentIndex Score
9 records- 0175US9863949B2Method for predicting and evaluating responsiveness to cancer treatment with DNA-damaging chemotherapeutic agentsNEKTAR THERAPEUTICS·Filed 2014·Granted Jan 9, 2018·3 cites·4 claims
- 0274US10132810B2Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitorNEKTAR THERAPEUTICS·Filed 2013·Granted Nov 20, 2018·3 cites·17 claims
- 0366US10653689B2Combination-based treatment methodNEKTAR THERAPEUTICS·Filed 2015·Granted May 19, 2020·1 cites·11 claims
- 0456US2019049450A1Method for Assessing and Predicting Efficacy of Breast Cancer Treatment with a Long-Acting Topoisomerase I InhibitorNEKTAR THERAPEUTICS·Filed 2018·Application pending·0 cites
- 0553US2018095085A1Method for predicting and evaluating responsiveness to cancer treatment with dna-damaging chemotherapeutic agentsNEKTAR THERAPEUTICS·Filed 2017·Application pending·0 cites
- 0651US2020237747A1Combination-based treatment methodNEKTAR THERAPEUTICS·Filed 2020·Application pending·0 cites
- 0746US2011293745A1Aurora kinase inhibitorsHOCH UTE·Filed 2009·Application pending·0 cites
- 0842US2021292415A1Methods of treating a tumorBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 0937US2014378404A1Treatment of Patients Suffering from CancerNEKTAR THERAPEUTICS·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ute Hoch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →